CJC-1295 with DAC is a long-acting growth hormone-releasing hormone analogue investigated for its effects on growth hormone secretion. The DAC modification extends its pharmacological activity. Research has demonstrated prolonged endocrine activity, but it remains investigational. Its potential applications in fitness, body composition, or performance are not established clinical indications, requiring appropriate scientific evaluation.